Comparative Efficacy and Safety of Daily Versus Alternate Day Dosing of Rosuvastatin in Dyslipidemic Patients: A Prospective, Randomized, Open Label Study. International Journal of Public Research in Medicine and Health, [S. l.], v. 1, n. 1, p. 10–19, 2025. DOI: 10.66328/ijprmh.2025.010103. Disponível em: https://ijprmh.com/journal/index.php/ijprmh/article/view/4. Acesso em: 19 apr. 2026.